Small interfering RNA (siRNA) targeting mouse GLUT1 designed according to reference20 (5′-GGAATTCAATGCTGATGATGA-3′, 5′-TCATCATCAGCATTGAATTCC-3′, GenePharma Co.) was used to block GLUT1 in BMDM. Non-targeted siRNA as a negative control (5′-TTCTCCGAACGTGTCACGT-3′, 5′-ACGTGACACGTTCGGAGAA-3′) was used in wells not transfected with GLUT1 siRNA. Normal saline-treated with diethyl pyrocarbonate (Sigma-Aldrich Corp. Ltd., MO, USA.) was used to dissolve siRNA to reach a 20 μmol·L−1 concentration. The transfection mixture per well was prepared using 5 μL Endofectin (GeneCopoeia Inc., USA) and 5 μL GLUT1 siRNA or noncoding siRNA. After transfection for 48 h, the GLUT1−/− BMDM was cultured as described above.
Copyright and License information: The Author(s) ©2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.